ReviewMolecular diversity2024

JAK2 inhibitors for the treatment of Philadelphia-negative myeloproliferative neoplasms: current status and future directions.

Xiaofeng Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.